Mirum Pharmaceuticals (MIRM) Change in Inventory (2021 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Change in Inventory of $1.9 million for Q1 2026, down 28.14% year-over-year from $2.7 million in Q1 2025, and down 15.86% quarter-over-quarter from $2.3 million in Q4 2025.
Analysis
Mirum Pharmaceuticals (MIRM) Change in Inventory (2021 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Change in Inventory history runs 6 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Change in Inventory fell 28.14% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $7.7 million (up 57.9% YoY), while the FY2025 annual figure was $8.4 million, up 166.84% from the prior year.
- Change in Inventory for Q1 2026 stood at $1.9 million, down from $2.3 million in the prior quarter.
- The five-year high for Change in Inventory was $2.8 million in Q3 2022, with the low at -$1.2 million in Q4 2023.
- The 5-year median for Change in Inventory is $989000.0 (2023), against an average of $1.1 million.
- The sharpest annual moves came in 2022 and 2023: Change in Inventory tumbled 220.81% in 2022, then soared 1061.19% in 2023.
- Mirum Pharmaceuticals' Change in Inventory stood at -$598000.0 in 2022, then plunged by 106.02% to -$1.2 million in 2023, then jumped by 117.37% to $214000.0 in 2024, then jumped by 966.36% to $2.3 million in 2025, then declined by 15.86% to $1.9 million in 2026.
- Business Quant data shows MIRM's Change in Inventory at $1.9 million in Q1 2026, $2.3 million in Q4 2025, and $1.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Mirum Pharmaceuticals | 6.40 Bn | 5.96 Bn | 145.90 Mn | -395,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -395,000.00 |
| Mar 31, 2026 | 1.92 Mn |
| Dec 31, 2025 | 2.28 Mn |
| Sep 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 2.34 Mn |
| Mar 31, 2025 | 2.67 Mn |
| Dec 31, 2024 | 214,000.00 |
| Sep 30, 2024 | 903,000.00 |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 964,000.00 |
| Dec 31, 2023 | -1.23 Mn |
| Sep 30, 2023 | 439,000.00 |
| Jun 30, 2023 | 989,000.00 |
| Mar 31, 2023 | 778,000.00 |
| Dec 31, 2022 | -598,000.00 |
| Sep 30, 2022 | 2.80 Mn |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 67,000.00 |
| Dec 31, 2021 | 495,000.00 |